Comparison of the efficacy of a 7-day versus a 14-day course of intravenous antibiotics in the treatment of uncomplicated neonatal bacterial sepsis: a randomized controlled non-inferiority trial

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Health Condition 1: P369- Bacterial sepsis of newborn, unspecifiedHealth Condition 2: null- Neonatal bacterial septicemia
Sponsor: Indian Council of Medical Research
Enrollment: 261
Status: Completed
Last Updated: 3 years ago

No summary available.

Registry

who.int

Start Date

TBD

End Date

January 30, 2023

Last Updated

3 years ago

Study Type

Interventional

Sponsor

•Inclusion criteria for the initial observational period:
•1\. Neonates aged 0\-28 days, either inborn or outborn, who are currently admitted in the Neonatal unit of the centre,
•2\. Whose birth weight is greater than 1500 grams (it should be reliably ascertained from records of a hospital),
•3\. Whose residence is within approximately 15 kms from the centre, so that the infant can be brought back to the centre for follow up.
•4\. Who have suspected septicemia for which a conventional or BACTEC/BACTALERT blood culture is sent and for which the treating physician decides to start antibiotics
•Randomization criteria applicable after 7 days of therapy of above patients with sensitive antibiotics:
•1\.Positive blood culture other than Staphylococcus aureus
•2\.No signs and symptoms of sepsis from end of day 5 through end of day 7 of starting sensitive antibiotics (This will be on day 5 through 7 for those who have improved and will be, for instance, day 8 through 10 for those whose initial empiric antibiotics were resistant requiring a change in antibiotic on day 3 of enrollment)

•Exclusion criteria for the initial observational period:
•1\. Central Nervous System infection (meningitis will be defined as one or more of CSF cell count \>\= 25 per microliter with \> 60% neutrophils; glucose \<20 mg/dl or CSF: blood glucose \<0\.6 or protein \>150 mg/dL in term or \>180 mg/dL in preterm or positive gram stain report)
•2\. Septic arthritis, osteomyelitis or deep\-seated abscess as clinically judged by the treating team
•3\. Life threatening congenital malformations as judged by the principal investigator of the centre
•Exclusion criteria for randomization applicable after 7 days of therapy of above patients with sensitive antibiotics:
•1\. Sterile blood culture
•2\. Suspected contaminants in blood culture.
•3\. Growth of Staphylococcus aureus in blood culture
•4\. Growth of fungal organism in blood culture
•5\. Diagnosis of meningitis, septic arthritis, osteomyelitis, abscess